Health

FDA approves Guardant360 CDx for ESR1 mutation testing in breast cancer

Guardant Health has received U.S. Food and Drug Administration (FDA) approval for Guardant360 CDx as a companion diagnostic to identify patients with hormone receptor (HR)-positive, HER2-negative...

by Editorial Team - MedTech World

Mon, 07 Sep 2026

MedTecpinion’s approach to reducing the total cost of oncology care

NIPRO CORPORATION receives FDA clearance for ELISIO-HX dialyzer for expanded hemodialysis

Lupin Dental gains UKCA certification, advancing UK market entry

Byonyks initiates U.S. commercial rollout of FDA-cleared X1 automated peritoneal dialysis cycler

A new chapter in lymphedema care: Sub-Q Bionics looks ahead to $5M seed round

Beyond pain management: Rethinking diabetic neuropathy as a progressive neurological disease

OpenAI for Healthcare: What the launch signals for the next phase of clinical AI

Abu Dhabi Public Health Centre advances epidemic preparedness with lab expansion

Bupa CareConnect and InterSystems partner to deliver a unified digital care experience across Saudi Arabia

1 … 10